Exchange: CSE·Updated 03:58 PM EDT

DTC.CSE Defence Therapeutics Inc

$0.51
$0.01
(2.00%)
Today
Mkt Cap$37.89M
Vol53,500.00

About DTC.CSE

Defence Therapeutics, Inc. engages in the research and development of anti-body drug conjugates. It focuses on enhancing intracellular delivery of biological or biosimilar therapeutic drugs targeting cancer and infectious diseases. The company was founded by Simon Beaudoin and Sébastien Plouffe on July 18, 2017 and is headquartered in Vancouver, Canada.
100

Extremely Bullish Sentiment

How do you feel about DTC.CSE?

Advertisement|Remove ads.